Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -3.93 Million GBP | 16.11% |
| 2022 | -4.68 Million GBP | -100.6% |
| 2021 | -2.33 Million GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -1.81 Million GBP | -199900.0% |
| 2023 FY | -3.93 Million GBP | 16.11% |
| 2023 Q4 | -1060.00 GBP | 0.0% |
| 2023 Q3 | -1060.00 GBP | 99.94% |
| 2023 Q1 | -905.50 GBP | 99.97% |
| 2022 Q2 | -1.6 Million GBP | -199900.0% |
| 2022 FY | -4.68 Million GBP | -100.6% |
| 2022 Q4 | -3.07 Million GBP | -199900.0% |
| 2022 Q3 | -1539.50 GBP | 99.9% |
| 2022 Q1 | -803.50 GBP | 0.0% |
| 2021 FY | -2.33 Million GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.17 Million USD | -23.95% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -5.95% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -65.108% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 107.42% |
| GB Sciences, Inc. | -1.36 Million USD | -188.688% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -29.902% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1623.163% |
| Skye Bioscience, Inc. | -37.64 Million USD | 89.558% |
| Zenith Capital Corp. | -10.59 Million USD | 62.901% |
| Agentix Corp. | -1.37 Million USD | -186.055% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 43.705% |
| Biomind Labs Inc. | -1.21 Million USD | -223.721% |
| ContraFect Corporation | -65.15 Million USD | 93.967% |
| CSL Limited | 2.64 Billion USD | 100.149% |
| CytoDyn Inc. | -49.84 Million USD | 92.113% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -101.667% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -521.593% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 93.72% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -846.137% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -115.926% |
| Regen BioPharma, Inc. | 1.02 Million USD | 484.071% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 106.035% |
| SQZ Biotechnologies Company | -79.46 Million USD | 95.053% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -81.168% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 94.756% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -35.908% |
| Mesoblast Limited | -87.95 Million USD | 95.531% |
| Marizyme, Inc. | -65.34 Million USD | 93.984% |
| Genus plc | 7.9 Million USD | 149.759% |
| Pharming Group N.V. | -10.54 Million USD | 62.732% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 55.552% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -127.56% |
| IMV Inc. | -36.48 Million USD | 89.226% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 51.226% |
| MultiCell Technologies, Inc. | -380.07 USD | -1034183.158% |
| ONE Bio Corp. | 8.67 Million USD | 145.306% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 92.395% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -5.304% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -26.734% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 50.26% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -26148.665% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 75.232% |
| Alpha Cognition Inc. | -13.77 Million USD | 71.458% |
| Enzolytics Inc. | -2.17 Million USD | -80.584% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 98.668% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 4111.224% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 156.769% |
| Genscript Biotech Corporation | -95.47 Million USD | 95.883% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 40.223% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -1337.81% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 5.184% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -6403.905% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -96.049% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 63.908% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 19.547% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -4.927% |
| Helix BioMedix, Inc. | -1.05 Million USD | -272.234% |
| EV Biologics, Inc. | -1.26 Million USD | -210.228% |
| Q BioMed Inc. | -2.05 Million USD | -91.561% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -2.933% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 93.418% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | 53.66% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 32.425% |
| HST Global, Inc. | -146.21 Thousand USD | -2588.599% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -194.362% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -124.018% |
| Halberd Corporation | -79.67 Thousand USD | -4833.732% |
| Resverlogix Corp. | -3.61 Million USD | -8.892% |
| Cell Source, Inc. | -5.32 Million USD | 26.126% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 1.057% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.41 Million USD | 38.709% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -16813.347% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | 17.575% |
| Kadimastem Ltd | -3.3 Million USD | -18.855% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 11.514% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -790.638% |
| LadRx Corporation | 400.44 Thousand USD | 1081.663% |
| Regen BioPharma, Inc. | 1.02 Million USD | 484.071% |
| Affymax, Inc. | -14.42 Million USD | 72.747% |
| Itoco Inc. | -1.86 Million USD | -110.327% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -135.53% |
| Mobile Lads Corp. | -2.26 Million USD | -73.685% |
| International Stem Cell Corporation | -131 Thousand USD | -2900.763% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -4.28 Million USD | 8.154% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -4873.872% |
| Qrons Inc. | -789.34 Thousand USD | -398.007% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -317.512% |
| SYBLEU INC | -180.3 Thousand USD | -2080.207% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -88.295% |
| Rebus Holdings, Inc. | -1.02 Million USD | -285.392% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -143.747% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -7143.146% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -55.36% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 91.823% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -85.951% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -403.402% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -24.085% |
| Neutra Corp. | -233.46 Thousand USD | -1583.764% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 80.627% |
| PureTech Health plc | -65.69 Million USD | 94.016% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 81.516% |
| IXICO plc | -1.17 Million USD | -233.701% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 60.401% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 93.119% |
| CSL Limited | 2.64 Billion USD | 100.149% |
| Cellectis S.A. | -103.17 Million USD | 96.19% |